Fibroblast Growth Factor-1 (FGF-1) for the Treatment of Coronary Heart Disease

Summary

Treatment for no-option heart patients with coronary artery disease. Procedure includes the injection into the heart of a protein growth factor, administered by the Biological Delivery Systems MyoStar injection and mapping catheters, to stimulate the growth of blood vessels around blocked coronary arteries.

Timeline

Start

2020-03

Primary completion

2022-03

Completion

2023-03

Drugs

Indications